THE MODE OF ACTION OF COLLOIDAL BISMUTH SUBCITRATE

被引:27
|
作者
LEE, SP [1 ]
机构
[1] VET ADM MED CTR,SEATTLE,WA 98108
关键词
COLLOIDAL BISMUTH SUBCITRATE; CYTOPROTECTION; GASTRODUODENAL DISORDERS; HELICOBACTER-PYLORI; MUCOPROTECTION;
D O I
10.3109/00365529109093213
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Colloidal bismuth subcitrate (CBS) is very effective in the treatment of gastroduodenal disorders and appears to act via several mechanisms. It has little acid-neutralizing effect and does not affect acid secretion. It is uncertain whether CBS affects pepsin secretion, but it does inhibit peptic activity. It causes an increase in mucus glycoprotein secretion and may also bind to the gastric mucus layer to act as a diffusion barrier to HCl. CBS accelerates ulcer healing and causes an accumulation of epidermal growth factor around the ulcer. In addition, it has a cytoprotective effect and increases mucosal secretion of prostaglandins and bicarbonate. CBS has bactericidal effects against Helicobacter pylori (which is associated with gastritis and peptic ulcers). It also prevents adhesion of H. pylori to epithelial cells and can inhibit enzymes secreted by H. pylori, such as proteases, lipases, glycosidases, and phospholipases.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [31] LONG-TERM TREATMENT OF DUODENAL-ULCER WITH COLLOIDAL BISMUTH SUBCITRATE - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    PORRO, GB
    LAZZARONI, M
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1991, 3 (03) : 223 - 228
  • [32] HELICOBACTER-PYLORI GASTRITIS IN DYSPEPTIC CHILDREN - A LONG-TERM FOLLOW-UP AFTER TREATMENT WITH COLLOIDAL BISMUTH SUBCITRATE AND TINIDAZOLE
    ASHORN, M
    RUUSKA, T
    KARIKOSKI, R
    MIETTINEN, A
    MAKI, M
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 (03) : 203 - 208
  • [33] Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori
    Lahaie, R
    Farley, A
    Dallaire, C
    Archambault, A
    Fallone, CA
    Ponich, T
    Hunt, R
    Oravec, M
    Whitsitt, P
    Van Zanten, SV
    Marcon, N
    Bailey, R
    Dumont, A
    Nguyen, B
    Desrochers, S
    Spénard, J
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 2001, 15 (09): : 581 - 585
  • [34] HELICOBACTER-PYLORI ERADICATION WITH DOXYCYCLINE METRONIDAZOLE BISMUTH SUBCITRATE TRIPLE THERAPY
    BORODY, TJ
    GEORGE, LL
    BRANDL, S
    ANDREWS, P
    LENNE, J
    MOOREJONES, D
    DEVINE, M
    WALTON, M
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1992, 27 (04) : 281 - 284
  • [35] COLLOIDAL BISMUTH SUBCITRATE-INDUCED CHANGES ON GASTRIC-MUCOSAL HEMODYNAMICS IN THE RAT - GASTRIC-MUCOSAL BLOOD-FLOW AFTER CBS TREATMENT
    ELEFTHERIADIS, E
    KOTZAMPASSI, K
    TZARTINOGLOU, E
    SALEM, A
    ALETRAS, H
    GASTROENTEROLOGIA JAPONICA, 1991, 26 (03): : 283 - 286
  • [36] PHARMACOLOGICAL EFFECTS OF METRONIDAZOLE PLUS TETRACYCLINE PLUS BISMUTH SUBCITRATE VERSUS OMEPRAZOLE PLUS AMOXICILLIN PLUS BISMUTH SUBCITRATE IN HELICOBACTER PYLORI-RELATED GASTRITIS AND PEPTIC-ULCER DISEASE
    PARK, KN
    HAHM, JS
    KIM, HJ
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1994, 6 : S103 - S107
  • [37] BISMUTH SUBCITRATE AND OMEPRAZOLE INHIBIT HELICOBACTER-PYLORI F1-ATPASE
    BEIL, W
    BIRKHOLZ, C
    WAGNER, S
    SEWING, KF
    PHARMACOLOGY, 1995, 50 (05) : 333 - 337
  • [38] Bismuth-based triple therapy with bismuth subcitrate, metronidazole and tetracycline in the eradication of Helicobacter pylori:: A randomized, placebo controlled, double-blind study
    van Zanten, SV
    Farley, A
    Marcon, N
    Lahaie, R
    Archambault, A
    Hunt, R
    Bailey, R
    Owen, D
    Spénard, J
    Stiglick, A
    Aimola, N
    Colin, P
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 14 (07): : 599 - 602
  • [39] Efficacy of a Modified Sequential Therapy Including Bismuth Subcitrate as First-Line Therapy to Eradicate Helicobacter pylori in a Turkish Population
    Uygun, Ahmet
    Ozel, A. Melih
    Sivri, Bulent
    Polat, Zulfikar
    Genc, Halil
    Sakin, Yusuf Serdar
    Celebi, Gurkan
    Uygur-Bayramicli, Oya
    Ercin, Cemal Nuri
    Kadayifci, Abdurrahman
    Emer, Ozdes
    Gunal, Armagan
    Bagci, Sait
    HELICOBACTER, 2012, 17 (06) : 486 - 490
  • [40] Efficacy of reduced-dose regimen of a capsule containing bismuth subcitrate, metronidazole, and tetracycline given with amoxicillin and esomeprazole in the treatment of Helicobacter Pylori infection
    Harb, Ali H.
    El Reda, Zeinab D.
    Sarkis, Fayez S.
    Chaar, Hani F.
    Sharara, Ala, I
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2015, 3 (01) : 95 - 96